Skip to main content

TEVA 5526 Pill - blue capsule-shape, 19mm

Pill with imprint TEVA 5526 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Atazanavir is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5526

Atazanavir sulfate 150 mg TEVA 5526
Atazanavir sulfate 150 mg TEVA 5526

Atazanavir Sulfate

TEVA 5526
150 mg
19.00 mm
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Pliva Hrvatska d.o.o.
National Drug Code (NDC)
Inactive Ingredients
D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, ferrosoferric oxide, lactose monohydrate, magnesium stearate, propylene glycol, shellac, sodium lauryl sulfate, sorbitan monolaurate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.